NCT04230252View on ClinicalTrials.gov

A Study of the Newly Formulated Tylenol Tablet (Acetaminophen) to the Tylenol 8 Hour (H) Extended Release (ER) Tablet (Acetaminophen) in Healthy Participants

PHASE1CompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

January 7, 2020

Primary Completion Date

February 10, 2020

Study Completion Date

March 23, 2020

Conditions
Healthy
Interventions
DRUG

Acetaminophen

Acetaminophen tablet will be administered orally in treatment sequence 1 and 2.

Trial Locations (1)

8779

H plus Yangji Hospital, Seoul

All Listed Sponsors
lead

Janssen Korea, Ltd., Korea

INDUSTRY

NCT04230252 - A Study of the Newly Formulated Tylenol Tablet (Acetaminophen) to the Tylenol 8 Hour (H) Extended Release (ER) Tablet (Acetaminophen) in Healthy Participants | Biotech Hunter | Biotech Hunter